Back in 2011 when Google+ emerged from Beta and started offering branded pages, there was a good deal of commentary in the blogosphere about the potential use for the new platform by pharma – even here at Eye on FDA. Now, nearly two years later, it seemed like a good time to check in and see what the experience has been.
